IC
IRWD icon

IEQ Capital’s Ironwood Pharmaceuticals IRWD Stock Holding History

IEQ Capital’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.36M Sell
561,588
-181,135
-24% -$698K 0.01% 742
2026
Q1 		$2.61M Buy
742,723
+109,463
+17% +$449K 0.01% 674
2025
Q4 		$2.13M Sell
633,260
-28,438
-4% -$73.9K 0.01% 768
2025
Q3 		$867K Buy
661,698
+169,816
+35% +$176K ﹤0.01% 1063
2025
Q2 		$353K Buy
491,882
+306,154
+165% +$240K ﹤0.01% 1321
2025
Q1 		$273K Buy
+185,728
New +$442K ﹤0.01% 1228

Other funds holding IRWD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

IEQ Capital's IRWD Position: Q2 2026 in Review

IEQ Capital reduced its Ironwood Pharmaceuticals (IRWD) stake by 24% in Q2 2026, selling an estimated $698K and leaving 561,588 shares worth $2.36M. The position accounts for 0.01% of the portfolio, ranked #742.

IEQ Capital first reported a position in IRWD in Q1 2025 and has held it in 6 quarters since. The position peaked at $2.61M in Q1 2026. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • IEQ Capital held 561,588 shares of Ironwood Pharmaceuticals worth $2.36M as of Q2 2026.
  • IEQ Capital sold 181,135 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $698K.
  • Ironwood Pharmaceuticals made up 0.01% of IEQ Capital's portfolio in Q2 2026, its #742 holding.
  • IEQ Capital first reported a position in Ironwood Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • IEQ Capital's Ironwood Pharmaceuticals position peaked at $2.61M in Q1 2026.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.